ARMOUR Residential REIT, Inc. vs BioNTech SE - ADR — how do they compare? ARMOUR Residential REIT, Inc. trades at $16.7 (market cap $2.07B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: BioNTech SE - ADR is far larger — about 11.3× ARMOUR Residential REIT, Inc.'s market cap, and ARMOUR Residential REIT, Inc. pays a 17.28% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| ARR | BNTX | |
|---|---|---|
Market Cap | $2.07B | $23.31B |
Sector | Financials | Health |
52-Week High | $19.12 | $119.34 |
52-Week Low | $14.05 | $83.89 |
Dividend Yield | 17.28% | — |
Enterprise Value | — | $6.60B |
Trailing returns across standard periods
ARMOUR Residential REIT Inc is a real estate investment trust that invests in residential mortgage-backed securities or RMBS. These are issued or guaranteed by U.S.-government-sponsored enterprises, such as Fannie Mae, Freddie Mac, or Ginnie Mae. The company's investment portfolio is composed of mortgage-backed securities, adjustable-rate mortgage securities, and multifamily mortgage-backed securities. In terms of total fair value, most Armour's investments are long-term, fixed-rate agency RMBS. Multifamily RMBS also represents a substantial amount. Fannie Mae guarantees most of the company's holdings. Armour derives substantially all its revenue as interest income from its investments.
Read more on ARR →BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →